Login / Register Order My Items
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

Custom Side-Chain Cyclic Peptide Synthesis

Internal macrocyclization (side-chain bridges) for stable, conformationally defined cyclic peptides—optimized for drug discovery, receptor ligands, constrained epitopes, protease-resistant tools, and SAR panels.

Lactam (Lys/Orn↔Asp/Glu) Disulfide (Cys–Cys) Thioether bridges Stapled peptides On-resin or solution HPLC/UPLC + LC‑MS QC
Request a Quote Speak to a Scientist
Talk to a chemist Request a quote
Overview Schematic Benefits Linkage options Specs Selection matrix How to choose Design tips Troubleshooting FAQ Contact

Overview

Side-chain cyclization is a form of internal macrocyclization in which reactive amino-acid side chains are covalently linked rather than connecting the N- and C-termini. Common linkages include lactam bridges (Lys/Orn ↔ Asp/Glu), disulfide loops (Cys–Cys), thioether bridges, and stapling-style constraints.

This strategy is often chosen when you need localized conformational control, improved stability, or SAR flexibility while keeping the N-terminus and/or C-terminus free for labeling, conjugation, or biological activity.

What is side-chain cyclization?

Side-chain cyclization forms a macrocycle by linking reactive side chains (thiols, amines, and/or carboxylates, or engineered handles). The bridge location is selectable, making it useful to stabilize a loop/turn, enforce a specific epitope geometry, or bias a helix (stapled designs).

Common synonyms: side-chain macrocycle, lactamization, disulfide loop formation, thioether bridge, stapled peptide.

side-chain cyclic peptide synthesis lactam bridge disulfide cyclization thioether macrocycle

Why side-chain cyclize?

  • Keep termini usable: preserve N/C termini for labeling, conjugation, or charge states.
  • Targeted constraint: stabilize a specific region without fully closing the backbone.
  • Protease resistance: can improve stability (sequence- and linkage-dependent).
  • SAR-friendly: bridge position can be scanned to optimize potency/selectivity.

Side-chain constraints can also be combined with head-to-tail closure to create bicyclic or multi-constrained architectures.

Best starting point

  • Lactam for robust, non-reducible loop constraints
  • Disulfide for natural folds and potential redox switching
  • Thioether for durable constraints in reducing environments

What to send for a quote

  • Sequence(s) + any non-standard residues
  • Preferred linkage (or “recommend”)
  • Free termini required? (N and/or C)
  • Quantity + purity target + application

Related pages: Peptide cyclization, Head-to-tail cyclic peptides, Stapled peptides, Click chemistry peptides.

Side-chain cyclization schematic

Linear precursor → internal bridge

We typically start from a linear sequence (commonly SPPS), then selectively expose the intended pair of side-chain handles, then form an intramolecular bridge. We often use orthogonal protecting groups and either on-resin pseudo-dilution or solution high-dilution strategies to suppress oligomers.

Linear peptide (protected) handle A (e.g., Lys/Orn NH₂ or Cys) handle B (e.g., Asp/Glu CO₂H or Cys) selective unmasking + intramolecular closure on-resin pseudo-dilution • high dilution • monitor by LC‑MS Side-chain cyclic peptide termini can remain free

Want two constraints? We can combine side-chain bridges with head-to-tail closure or add a second internal bridge for bicyclic designs.

What we optimize (real-world)

  • Protecting-group plan: orthogonal unmasking of only the intended pair
  • On-resin vs solution: pseudo-dilution vs condition control
  • Linkage selection: lactam vs disulfide vs thioether vs staple
  • Side reactions: suppress oligomers and reduce disulfide scrambling
  • Purification plan: anticipate retention shifts vs linear precursor
Request a Quote View selection matrix

For quoting: send sequence + desired linkage type (or “recommend”), whether termini must remain free, and target purity/quantity.

Benefits (why internal bridges are popular)

Keep termini usable

Preserve N/C termini for labeling, conjugation, or charge-state requirements.

Local structure control

Lock a loop/turn/segment without forcing a full backbone ring.

Linkage flexibility

Choose reducible (disulfide) or robust (lactam/thioether) bridges based on context.

SAR-friendly panels

Scan bridge position to optimize potency, selectivity, or stability.

Helix bias (stapling)

Stapling can stabilize helices for PPI targets (design-dependent).

Combine constraints

Pair side-chain bridges with head-to-tail closure for bicyclic designs.

Linkage options we support

Side-chain lactam cyclization (Lys/Orn ↔ Asp/Glu) stable amide bridge • common
lactam bridgeorthogonal protectionon-resin or solution

Intramolecular amide bond between a side-chain amine (Lys/Orn) and side-chain acid (Asp/Glu). Often the best starting point when you want a robust, non-reducible constraint with predictable performance.

Disulfide cyclization (Cys–Cys) natural loop • redox-sensitive
disulfide oxidation control scrambling mitigation

Disulfide loops are common in natural bioactive peptides. If multiple cysteines are present, specify connectivity requirements so we can prioritize a strategy that reduces mixed disulfides and scrambling.

Thioether bridges durable • typically redox-stable
thioether stable constraint sequence-dependent selectivity

Thioether bridges are a common alternative when disulfides are unstable in reducing environments. We’ll align the plan to the sequence and required topology.

Stapled peptides (helix-stabilizing constraints) PPI targets • design-critical
stapled peptide helicity PPI leads

Stapling creates a side-chain constraint that biases α-helicity. If you’re exploring a target interface, we can build matched variants to balance helicity vs activity tolerance.

Hybrid cyclization (terminus-to-side-chain) keep one terminus free
terminus-to-side-chain conjugation-ready practical yields

Useful when you need a strong constraint but must keep one terminus available for conjugation or function.

Specifications & typical deliverables

Typical deliverables

  • Purified cyclic peptide (lyophilized)
  • Analytical HPLC/UPLC chromatogram (purity)
  • Mass confirmation by LC‑MS when feasible
  • Certificate of Analysis (COA)

Need matched controls (linear vs cyclic, alternative linkage types, oxidized vs reduced disulfide states)? Mention it up front.

Request a Quote Talk to a Scientist

How to specify your order

Item What to provide
Sequence AA sequence + any non-standard residues + disulfide connectivity (if applicable)
Linkage type Lactam / disulfide / thioether / staple / hybrid (or “recommend”) + whether termini must remain free
Quantity Target amount (mg) and acceptable minimum
Purity Crude / desalted / purified (e.g., ≥90% / ≥95% / ≥98%)
Application Assay, binding, cell work, conjugation, MS standard, etc.
QC Standard HPLC + MS (when feasible), or add application-specific analytics as needed

Selection matrix: linkage types & best use-cases

The best linkage depends on stability requirements (especially redox), geometry constraints, and the chemistry your sequence can support. Here is a practical selection matrix for planning and ordering.

Linkage Typical handles Strengths Best fit
Lactam Lys/Orn ↔ Asp/Glu Robust, non-reducible, predictable Stable loops/turns; SAR panels; therapeutic-like constraints
Disulfide Cys ↔ Cys Natural, reversible, compact folds Extracellular targets; redox-responsive function; natural-mimic scaffolds
Thioether Cys-based Durable, typically redox-stable Reducing environments; “set-and-forget” stability
Stapled Designed side-chain handles Strong conformational bias (often α-helix) PPI target exploration; helix-driven SAR
Hybrid Terminus ↔ side chain Constraint + preserved terminus Conjugation-ready probes; topology constraints with terminal functionality

How to choose (quick decision guide)

Start with the assay environment

  • Reducing conditions expected? Consider lactam or thioether over disulfide.
  • Redox switching desired? Disulfide may be a feature.
  • Need stable local constraint? Lactam is often the default starting point.
  • Need helix stabilization? Consider stapled designs.

Then check feasibility

  • Handle placement: keep bridge away from key pharmacophore residues.
  • Competing handles: extra thiols/amines/acids may require tighter protection strategy.
  • Aggregation risk: hydrophobic sequences can promote intermolecular coupling.
  • Analytics plan: when mass is ambiguous, plan orthogonal confirmation.

Design tips that improve success rate

Choose the right handle pair

Lys/Orn ↔ Asp/Glu is often the simplest robust starting pair; Cys strategies are powerful but can require oxidation/control.

Avoid ring strain extremes

Very short bridges or tight spacing can lower conversion and increase byproducts; consider alternate spacing or hybrid constraints.

Plan for selectivity

Multiple reactive side chains can create competing products—orthogonal protection is often the difference-maker.

Decide on termini early

If termini must remain free, side-chain or hybrid closure is usually preferred over head-to-tail closure.

Use matched controls

Linear vs cyclic, disulfide vs thioether, bridge position variants—these accelerate SAR and de-risk interpretation.

Define disulfide connectivity

If multiple cysteines are present, specify desired connectivity to help reduce scrambling and mixed species.

Troubleshooting (common failure modes & fixes)

The most common side-chain cyclization issues are incomplete unmasking, intermolecular coupling (dimers/oligomers), and (for disulfides) scrambling/mixed disulfides. Strong protection planning + pseudo-dilution/high-dilution + LC‑MS monitoring usually resolves most problems.

Symptom Likely cause Typical fix
No cyclic product Incomplete selective deprotection; wrong handle pairing; strain Verify unmasking (LC‑MS); adjust protection plan; consider alternate spacing/handles
Oligomers / dimers Effective concentration too high; aggregation; multiple competing sites On-resin pseudo-dilution or higher dilution; slow addition; tighten selectivity
Disulfide scrambling Multiple Cys; uncontrolled oxidation; mixed disulfides Define connectivity; control oxidation; selective Cys protection strategy
Multiple peaks same mass Conformers/isomers; competing linkage sites Improve selectivity; confirm by MS/MS or other orthogonal evidence

If you already tried synthesis elsewhere, share method + chromatogram/MS summary—diagnosis is much faster with that context.

FAQ

What is side-chain cyclization?

Macrocyclization by linking side-chain functional groups (lactam, disulfide, thioether, staples), often preserving one or both termini.

Which linkage is most stable?

Lactams and thioethers are typically more redox-stable than disulfides; the best choice depends on your assay environment and design constraints.

Can I keep N-terminus or C-terminus free?

Yes—this is a common reason to choose side-chain cyclization or a hybrid terminus-to-side-chain approach.

Do you offer on-resin cyclization?

When appropriate, yes. On-resin pseudo-dilution can reduce intermolecular coupling; the best route depends on sequence and handle plan.

How do you confirm cyclization?

Analytical HPLC/UPLC plus MS (when feasible) are standard. If mass is ambiguous, we may recommend orthogonal confirmation depending on linkage and goals.

Can you provide matched sets?

Yes—linear vs cyclic controls and linkage/position variants are common for SAR and stability comparisons.

More FAQ'sAll FAQ's

Contact & quote request

For the fastest quote, send your sequence(s), preferred linkage type (or “recommend”), whether termini must remain free, purity/quantity targets, and application.

Fast quote checklist

  • Sequence(s) + any non-standard residues
  • Desired linkage (lactam/disulfide/thioether/staple/hybrid)
  • Free termini required? (N and/or C)
  • Quantity (mg) + purity target
  • Intended use (assay, binding, cell work, conjugation)
  • Any constraints (must keep motif unchanged)

Fastest path

Request a Quote See linkage options

Recommended reading

Background on cyclic peptide design, side-chain linkages, and constrained scaffold property tuning.

Want references focused on your specific linkage type and target class? Share your use case and we’ll tailor the list.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links